Litcius/Paper detail

Febuxostat and renal outcomes: post-hoc analysis of a randomized trial

Kentaro Kohagura, Sunao Kojima, Kazuaki Uchiyama, Naoto Yokota, Eiichi Tokutake, Yutaka Wakasa, Shinya Hiramitsu, Masako Waki, Hideaki Jinnouchi, Hirokazu Kakuda, Takahiro Hayashi, Naoki Kawai, Masahiro Sugawara, Hisao Mori, Kenichi Tsujita, Kunihiko Matsui, Ichiro Hisatome, Yusuke Ohya, Kazuo Kimura, Yoshihiko Saito, Hisao Ogawa, on behalf of the Febuxostat for Cerebral and Cardiorenovascular Events Prevention Study (FREED) investigators

2023Hypertension Research14 citationsDOI

Topics & Concepts

FebuxostatMedicineHyperuricemiaPost-hoc analysisMicroalbuminuriaInternal medicineAsymptomaticHazard ratioRenal functionRandomized controlled trialUrologyUric acidConfidence intervalGout, Hyperuricemia, Uric AcidAlcohol Consumption and Health EffectsLiver Disease and Transplantation
Febuxostat and renal outcomes: post-hoc analysis of a randomized trial | Litcius